doi: 10.1038/nm.1927 79 SaenzBPerezHJChavarriaA
Then, in February 2025, FDA removed semaglutide from its shortage list, giving some pharmacies, called 503A pharmacies, until April 22, 2025, to stop dispensing exact copies of semaglutide, and others, so-called 503B pharmacies, until May 22, 2025
And by adding the new category of GLP-1 medications, especially for that hard to lose stubborn weight, in lowest effective doses, to our already proven strategies, our patients are now achieving faster, more dramatic, and more sustained weight loss than ever before
As a physician and a patient of the system, it is incredibly frustrating to see how it has been built